Current innovations in sentinel lymph node mapping for the staging and treatment of resectable lung cancer.
about
Clinical implications of transforming growth factor-beta-induced gene-h3 protein expression in lung cancer.Four percent matters.Polymorphisms of the stem cell marker gene CD133 are associated the clinical outcome in a cohort of Chinese non-small cell lung cancer patients.Long-term outcomes after near-infrared sentinel lymph node mapping in non-small cell lung cancer.An open label trial of folate receptor-targeted intraoperative molecular imaging to localize pulmonary squamous cell carcinomas.Sentinel lymph node mapping in lung cancer: a step forward?
P2860
Current innovations in sentinel lymph node mapping for the staging and treatment of resectable lung cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Current innovations in sentine ...... ent of resectable lung cancer.
@en
type
label
Current innovations in sentine ...... ent of resectable lung cancer.
@en
prefLabel
Current innovations in sentine ...... ent of resectable lung cancer.
@en
P2860
P1476
Current innovations in sentine ...... ent of resectable lung cancer.
@en
P2093
Krista J Hachey
Yolonda L Colson
P2860
P304
P356
10.1053/J.SEMTCVS.2014.09.001
P577
2014-09-16T00:00:00Z